Myriad Genetics pulls sales forecast as coronavirus disrupts operations

[cafead]

via Myriad Genetics, one of the largest genetic testing companies, has retracted its sales forecasts for its 2020 fiscal year, citing disruptions to its business as a result of the COVID-19 pandemic.

article source